BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05243641-completion@plaintrial.com
DTSTAMP:20260928T070538Z
DTSTART;VALUE=DATE:20241119
SUMMARY:Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Br
 east Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-fami
 ly and c-Met Pathway Activity as Measured by the CELsignia Signaling Analy
 sis Test — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05243641
URL:https://plaintrial.com/trial/NCT05243641
END:VEVENT
END:VCALENDAR